(NaturalNews) A doctor and professor of medicine at the University of Alberta in Canada claims to have identified a novel substance that he says demonstrably kills cancer cells without causing harmful side effects and yet costs just pennies a dose. It is known as dichloroacetic acid, or DCA, and Dr. Evangelos Michelakis, M.D., believes it could be the next breakthrough treatment in the fight against cancer, that is if a government entity or pharmaceutical company would ever be willing to put forth appropriate funding for human clinical trials.
But this is unlikely to happen anytime soon, as there is currently no patent on DCA, and thus no incentive for private industry to research its potential benefits as a cancer treatment -- it's all about the money, after all, not public health. And governments are likely to ignore DCA as well, even though the medical research funds they disburse are intended for this very type of research, which is otherwise overlooked by the private sector in favor of more profitable undertakings.
But that has not stopped Dr. Michelakis from conducting his own research on animals, which thus far has shown some promising outcomes in targeting cancer cells and tumors. A recent report aired by CTV News
in Canada explains how DCA, a drug that has actually been around for quite a while, is finding new vigor as an effective cancer treatment. What has long been used as a treatment merely for certain rare medical conditions could also be a, dare we say it, cure for cancer.
Based on initial trials, mice intentionally bred with certain human cancers responded positively to DCA
when it was added to their drinking water. Brain, breast and lung tumors, it turns out, shrunk by an astounding 70 percent after just three weeks of treatment with DCA. And according to Dr. Michelakis, the drug compound did not cause any harmful side effects, leaving fully intact healthy cells and other tissues that are otherwise damaged by conventional chemotherapy or radiation treatments.
Not only this, but DCA also appears to help reanimate the energy-producing mechanisms found in healthy cells, which are known as mitochondria, giving them new life. Once activated and brought up to speed, these mitochondria elicit new abilities to trigger cancer
apoptosis, or cancer cells essentially committing suicide on their own.
"These kinds of results, in my mind, are as good as it gets," stated Dr. Michelakis to CTV News
about his findings. "We hope that we can attract the interest of universities here in Canada and in the United States."
Cheap, effective and patent-free means Big Pharma isn't interested
What it would take, according to general estimates, is about $100 million dollars and many years' worth of testing and trials to get DCA approved as an officially recognized treatment for cancer here in North America. Time will tell whether or not any of this actually happens though, as the pharmaceutical industry keeps a pretty tight lid on anything having to do with cancer treatments, since the cancer industry is a multi-billion dollar profit machine.
"This is exactly what we want is a drug that has activity, and that also has minimal side effects for patients," added Dr. Dario Altieri from the University of Massachusetts about the promising benefits of DCA.
You can view the full CTV News
segment on DCA at LiveLeak.com
Dr. Michelakis was also recently interviewed by television personality Glenn Beck:http://youtube.com
You can also learn more about Dr. Michelakis' work by visiting Canadians for Health Research:http://www.chrcrm.orgSources for this article include:http://www.liveleak.comhttp://www.chrcrm.orghttp://youtube.com